A study to assess Covid-19 Vaccine effectiveness against the Omicron and delta variants in England
Latest Information Update: 10 Mar 2022
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 10 Mar 2022 New trial record
- 02 Mar 2022 Results published in the New England Journal of Medicine